Business Description
Voyageur Pharmaceuticals Ltd
NAICS : 325410
SIC : 3741
ISIN : CA92916K1057
Description
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.9 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -9.5 | |||||
3-Year FCF Growth Rate | -2 | |||||
3-Year Book Growth Rate | -18.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.78 | |||||
9-Day RSI | 60.88 | |||||
14-Day RSI | 59.21 | |||||
3-1 Month Momentum % | -31.59 | |||||
6-1 Month Momentum % | -39.8 | |||||
12-1 Month Momentum % | -68.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.18 | |||||
Quick Ratio | 0.12 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 1156.23 | |||||
Days Sales Outstanding | 1351.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -10780.65 | |||||
Net Margin % | -10780.65 | |||||
EBITDA Margin % | -10780.65 | |||||
FCF Margin % | -6369.57 | |||||
OCF Margin % | -6369.57 | |||||
ROE % | -306.27 | |||||
ROA % | -105.49 | |||||
ROIC % | -127.69 | |||||
3-Year ROIIC % | -266.62 | |||||
ROC (Joel Greenblatt) % | -139.54 | |||||
ROCE % | -295.28 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -7.87 | |||||
EV-to-EBITDA | -7.87 | |||||
EV-to-Revenue | 825.43 | |||||
EV-to-FCF | -12.96 | |||||
Earnings Yield (Greenblatt) % | -12.71 | |||||
FCF Yield % | -7.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VYYRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Voyageur Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.023 | ||
| EPS (TTM) ($) | -0.007 | ||
| Beta | -30.8745 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 13.64 | ||
| Volatility % | 181.71 | ||
| 14-Day RSI | 59.21 | ||
| 14-Day ATR ($) | 0.017215 | ||
| 20-Day SMA ($) | 0.0426 | ||
| 12-1 Month Momentum % | -68.32 | ||
| 52-Week Range ($) | 0.0033 - 0.24 | ||
| Shares Outstanding (Mil) | 179.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Voyageur Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Voyageur Pharmaceuticals Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Voyageur Pharmaceuticals Ltd Frequently Asked Questions
What is Voyageur Pharmaceuticals Ltd(VYYRF)'s stock price today?
The current price of VYYRF is $0.10. The 52 week high of VYYRF is $0.24 and 52 week low is $0.00.
When is next earnings date of Voyageur Pharmaceuticals Ltd(VYYRF)?
The next earnings date of Voyageur Pharmaceuticals Ltd(VYYRF) is .
Does Voyageur Pharmaceuticals Ltd(VYYRF) pay dividends? If so, how much?
Voyageur Pharmaceuticals Ltd(VYYRF) does not pay dividend.
Guru Commentaries on OTCPK:VYYRF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Voyageur Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers